Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
USOTC
PharmaTher Holdings Ltd (QB) (PHRRF)
PharmaTher Holdings Ltd (QB) (PHRRF) News

PharmaTher (QB) (PHRRF)

PharmaTher Holdings Ltd (QB)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PHRRF

1

Date	Time	Source	Headline	Symbol	Company
19/09/2022	10:31	TipRanks	Analysts Offer Insights on Healthcare Companies: PharmaTher Holdings Ltd (OtherPHRRF), Rezolute (RZLT) and ADC Therapeutics (ADCT)	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
15/06/2022	09:03	TipRanks	H.C. Wainwright Keeps a Buy Rating on PharmaTher Holdings Ltd (PHRRF)	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
22/11/2021	11:16	TipRanks	H.C. Wainwright Thinks NPharmaTher’s Stock is Going to Recover	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
11/11/2021	15:00	InvestorsHub NewsWire	PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
03/11/2021	12:03	InvestorsHub NewsWire	PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
19/10/2021	11:07	InvestorsHub NewsWire	PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
13/10/2021	13:20	InvestorsHub NewsWire	PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
21/09/2021	14:19	InvestorsHub NewsWire	PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
13/09/2021	13:03	InvestorsHub NewsWire	PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
04/08/2021	12:15	InvestorsHub NewsWire	PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
21/07/2021	12:19	InvestorsHub NewsWire	PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
16/06/2021	15:14	InvestorsHub NewsWire	PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
25/05/2021	12:45	InvestorsHub NewsWire	PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
17/05/2021	12:02	InvestorsHub NewsWire	PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson's Disease	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
27/04/2021	11:47	InvestorsHub NewsWire	PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics..Cont	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
20/04/2021	12:00	InvestorsHub NewsWire	PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
15/04/2021	15:32	InvestorsHub NewsWire	PharmaTher Provides Update on Psychedelic Product Programs	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
02/03/2021	12:34	InvestorsHub NewsWire	PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou....Cont	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
17/02/2021	15:11	InvestorsHub NewsWire	PharmaTher Announces Sale of Psilocybin Program	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
04/02/2021	13:21	InvestorsHub NewsWire	PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
01/02/2021	13:19	InvestorsHub NewsWire	PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
19/01/2021	13:07	InvestorsHub NewsWire	PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)

Showing the most relevant articles for your search:USOTC:PHRRF

1

Super Micro Computer

Red Rock Resources

Sirius Petroleum

Anglo Asian Mining

Skinbiotherapeutics

Liontrust Asset Management

Nextenergy Solar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions